1875 — TOT Biopharm International Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$1.65bn
- HK$1.65bn
- CNY780.63m
- 17
- 23
- 71
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 571 | 226 | 153 | 458 | 352 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 16.9 | 6.75 | 27 | 62.7 | 143 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 614 | 249 | 306 | 677 | 693 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 338 | 311 | 379 | 563 | 712 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,017 | 641 | 710 | 1,262 | 1,426 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 147 | 52.7 | 261 | 275 | 382 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 159 | 58.8 | 375 | 548 | 739 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 858 | 582 | 335 | 714 | 687 |
Total Liabilities & Shareholders' Equity | 1,017 | 641 | 710 | 1,262 | 1,426 |
Total Common Shares Outstanding |